| |
| |
|
| Insider
Information: |
Harris Robert Paul |
| Relationship: |
Director |
| City: |
Milton |
| State: |
A6 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,476,594 |
|
|
Indirect Shares
|
8,850,188 |
|
|
| Direct
Value |
$1,504 |
|
|
|
Indirect Value
|
$1,500 |
|
|
| Total
Shares |
18,326,782 |
|
|
| Total
Value |
$3,004 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tribute Pharmaceuticals |
TBUFF |
Chief Executive Office... |
2013-02-27 |
8,875,000 |
2012-03-22 |
8,250,000 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-11 |
601,594 |
2017-05-11 |
600,188 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
601,594 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-29 |
4 |
AS |
$4.99 |
$523,146 |
D/D |
(104,778) |
594,094 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-29 |
4 |
OE |
$3.92 |
$410,730 |
D/D |
104,778 |
698,872 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-28 |
4 |
AS |
$4.65 |
$93,000 |
D/D |
(20,000) |
594,094 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-28 |
4 |
OE |
$3.92 |
$78,400 |
D/D |
20,000 |
614,094 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-09-15 |
4 |
AS |
$5.60 |
$873,218 |
D/D |
(150,000) |
594,094 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
744,094 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
600,188 |
|
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
736,594 |
|
- |
|
| TBUFF |
Tribute Pharmaceuticals |
Chief Executive Officer |
• • – |
2013-02-27 |
4 |
B |
$0.40 |
$250,000 |
D/D |
625,000 |
8,875,000 |
2.81 |
- |
|
| TBUFF |
Tribute Pharmaceuticals |
Chief Executive Officer |
• • – |
2012-03-22 |
4 |
B |
$0.56 |
$308,000 |
I/I |
550,000 |
8,250,000 |
2.66 |
- |
|
| TBUFF |
Tribute Pharmaceuticals |
Chief Executive Officer |
• • – |
2012-03-22 |
4 |
B |
$0.56 |
$308,000 |
D/D |
550,000 |
7,700,000 |
2.81 |
- |
|
| TBUFF |
Tribute Pharmaceuticals |
President & CEOOfficer |
• • • |
2011-12-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,575,000 |
|
- |
|
| TBUFF |
Tribute Pharmaceuticals |
President & CEOOfficer |
• • • |
2011-12-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,575,000 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
